We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch
Read MoreHide Full Article
Key Takeaways
CLB's Q2 revenues are projected at $129.3M, down 1% year over year.
Reservoir and production segment sales are likely to have fallen due to tariffs and global uncertainties.
CLB's operating expenses are expected to rise 0.4%, potentially pressuring its profit margins.
Core Laboratories Inc. (CLB - Free Report) is set to release second-quarter 2025 results on July 23, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 18 cents per share on revenues of $129.3 million.
Let us delve into the factors that might have influenced CLB’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.
Highlights of Q1 Earnings & Surprise History
In the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s adjusted earnings missed the consensus mark. CLB reported adjusted earnings of 14 cents per share, which was a cent lower than the Zacks Consensus Estimate. This was attributed to poor performance from its Reservoir Description segment. Operating revenues of $124 million were in line with the Zacks Consensus Estimate.
CLB’s earnings missed the Zacks Consensus Estimate in two of the trailing four quarters, were in line in one quarter and beat the remaining one, delivering an average negative surprise of 1.6%.
The Zacks Consensus Estimate for second-quarter 2025 earnings has not witnessed any movement in the past seven days. The estimated figure indicates an 18.2% year-over-year decline. The Zacks Consensus Estimate for revenues also indicates a decline of about 1% from the year-ago period’s actual. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Factors to Consider Ahead of CLB’s Q2 Release
The company primarily makes money through its reservoir description and production enhancement services, which analyze and optimize oil and gas extraction processes.
CLB’s revenues are likely to have declined in the quarter to be reported. This can be attributed to the weak performance of both the Reservoir Description segment and the Production Enhancement segment. Revenues in the Reservoir Description segment are expected to decrease 0.7% year over year, reaching $85.7 million due to various factors like global economic uncertainties, geopolitical risk and trade sanctions. The Production Enhancement segment’s revenues are anticipated to decrease 1.6% year over year, reaching $43.6 million, which can be attributed to the adverse impact of the recent tariff announcements.
Moreover, the increase in CLB's costs is likely to have affected its bottom line. The company’s second-quarter total operating expenses are likely to be $115.1 million, up 0.4% from the year-ago quarter’s level. Its services and product sales costs are also expected to increase from $102.9 million to $104.8 million in the same time frame.
On a positive note, CLB expects international project activity to be steady in the upcoming quarter, with committed long-term upstream projects from the South Atlantic Margin, North and West Africa, Norway, the Middle East and certain areas of Asia Pacific.
What Does Our Model Say About CLB Stock?
Our proven model does not conclusively predict an earnings beat for Core Laboratories this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here.
CLB’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
CLB’s Zacks Rank: CLB currently carries a Zacks Rank #5 (Strong Sell).
Stocks With the Favorable Combination
Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
OVV is scheduled to release earnings on July 24. Notably, Ovintiv’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 27.8%. Valued at around $10.5 billion, OVV’s shares have lost 18.9% in a year.
TotalEnergies SE (TTE - Free Report) has an Earnings ESP of +0.05% and a Zacks Rank #3. TTE is slated to release earnings on July 24.
The Zacks Consensus Estimate for Total Energies’ second-quarter 2025 earnings has been revised 2.4% upward in the past 30 days. Valued at around $148.9 billion, TTE’s shares have lost 9.6% in a year.
Hess Corporation (HES - Free Report) has an Earnings ESP of +1.81% and a Zacks Rank #3. HES is scheduled to release earnings on July 30.
The Zacks Consensus Estimate for Hess’ second-quarter 2025 earnings has been revised 5.7% upward in the past 30 days. Valued at around $46 billion, HES’ shares have lost 4.4% in a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch
Key Takeaways
Core Laboratories Inc. (CLB - Free Report) is set to release second-quarter 2025 results on July 23, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 18 cents per share on revenues of $129.3 million.
Let us delve into the factors that might have influenced CLB’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.
Highlights of Q1 Earnings & Surprise History
In the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s adjusted earnings missed the consensus mark. CLB reported adjusted earnings of 14 cents per share, which was a cent lower than the Zacks Consensus Estimate. This was attributed to poor performance from its Reservoir Description segment. Operating revenues of $124 million were in line with the Zacks Consensus Estimate.
CLB’s earnings missed the Zacks Consensus Estimate in two of the trailing four quarters, were in line in one quarter and beat the remaining one, delivering an average negative surprise of 1.6%.
This is depicted in the graph below:
Core Laboratories Inc. Price and EPS Surprise
Core Laboratories Inc. price-eps-surprise | Core Laboratories Inc. Quote
CLB Stock’s Trend in Estimate Revision
The Zacks Consensus Estimate for second-quarter 2025 earnings has not witnessed any movement in the past seven days. The estimated figure indicates an 18.2% year-over-year decline. The Zacks Consensus Estimate for revenues also indicates a decline of about 1% from the year-ago period’s actual. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Factors to Consider Ahead of CLB’s Q2 Release
The company primarily makes money through its reservoir description and production enhancement services, which analyze and optimize oil and gas extraction processes.
CLB’s revenues are likely to have declined in the quarter to be reported. This can be attributed to the weak performance of both the Reservoir Description segment and the Production Enhancement segment. Revenues in the Reservoir Description segment are expected to decrease 0.7% year over year, reaching $85.7 million due to various factors like global economic uncertainties, geopolitical risk and trade sanctions. The Production Enhancement segment’s revenues are anticipated to decrease 1.6% year over year, reaching $43.6 million, which can be attributed to the adverse impact of the recent tariff announcements.
Moreover, the increase in CLB's costs is likely to have affected its bottom line. The company’s second-quarter total operating expenses are likely to be $115.1 million, up 0.4% from the year-ago quarter’s level. Its services and product sales costs are also expected to increase from $102.9 million to $104.8 million in the same time frame.
On a positive note, CLB expects international project activity to be steady in the upcoming quarter, with committed long-term upstream projects from the South Atlantic Margin, North and West Africa, Norway, the Middle East and certain areas of Asia Pacific.
What Does Our Model Say About CLB Stock?
Our proven model does not conclusively predict an earnings beat for Core Laboratories this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here.
CLB’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
CLB’s Zacks Rank: CLB currently carries a Zacks Rank #5 (Strong Sell).
Stocks With the Favorable Combination
Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
Ovintiv Inc. (OVV - Free Report) has an Earnings ESP of +2.34% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
OVV is scheduled to release earnings on July 24. Notably, Ovintiv’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 27.8%. Valued at around $10.5 billion, OVV’s shares have lost 18.9% in a year.
TotalEnergies SE (TTE - Free Report) has an Earnings ESP of +0.05% and a Zacks Rank #3. TTE is slated to release earnings on July 24.
The Zacks Consensus Estimate for Total Energies’ second-quarter 2025 earnings has been revised 2.4% upward in the past 30 days. Valued at around $148.9 billion, TTE’s shares have lost 9.6% in a year.
Hess Corporation (HES - Free Report) has an Earnings ESP of +1.81% and a Zacks Rank #3. HES is scheduled to release earnings on July 30.
The Zacks Consensus Estimate for Hess’ second-quarter 2025 earnings has been revised 5.7% upward in the past 30 days. Valued at around $46 billion, HES’ shares have lost 4.4% in a year.